Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [5126]
News [14840]
Articles [105]
Editorials [3]
Conferences [245]
elearning [21]
Modern antiematogenic therapy from 5-HT3 to NK-1 antagonists
Dr Sayeh Lavasani - Memorial Cancer Institute, Hollywood, Florida, USA
Modern antiematogenic therapy from 5-HT3 to NK-1 antagonists ( Dr Sayeh Lavasani - Memorial Cancer Institute, Hollywood, Florida, USA )
25 Jul 2016
Editor's Choice for July 2016
Prof Gordon McVie - Editor in Chief, ecancer
Editor's Choice for July 2016 ( Prof Gordon McVie - Editor in Chief, ecancer )
25 Jul 2016
The steady progress of targeted therapies
Dr Anton Berns - Netherlands Cancer Institute, Amsterdam, Netherlands
The steady progress of targeted therapies ( Dr Anton Berns - Netherlands Cancer Institute, Amsterdam, Netherlands )
20 Jul 2016
Towards deciphering the functional genetics and neo-antigenic landscape in...
Prof Yardena Samuels - Weizmann Institute of Science, Rehovot, Israel
Towards deciphering the functional genetics and neo-antigenic landscape in melanoma ( Prof Yardena Samuels - Weizmann Institute of Science, Rehovot, Israel )
18 Jul 2016
Prof Michael Seckl: Why attend Future Horizons in Lung Cancer?
Prof Michael Seckl - Imperial College London, London
Prof Michael Seckl: Why attend Future Horizons in Lung Cancer? ( Prof Michael Seckl - Imperial College London, London )
17 Jul 2016
Polycomb repressors and epigenetic therapy
Dr Maarten van Lohuizen - Netherlands Cancer Institute, Netherlands, UK
Polycomb repressors and epigenetic therapy ( Dr Maarten van Lohuizen - Netherlands Cancer Institute, Netherlands, UK )
15 Jul 2016
DNA repair and mutations as targets for personalised therapy
Prof Zoltan Szallasi - Boston Children's Hospital, Boston, USA
DNA repair and mutations as targets for personalised therapy ( Prof Zoltan Szallasi - Boston Children's Hospital, Boston, USA )
15 Jul 2016
The changing process of drug discovery and design
Dr Ian Waddell - Cancer Research UK Manchester Institute, Manchester, UK
The changing process of drug discovery and design ( Dr Ian Waddell - Cancer Research UK Manchester Institute, Manchester, UK )
14 Jul 2016
Glioblastoma heterogeneity in circulating tumour DNA
Dr Joan Seoane - Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain
Glioblastoma heterogeneity in circulating tumour DNA ( Dr Joan Seoane - Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain )
14 Jul 2016
Obesity promotes pancreatic cancer progression and resistance
Dr Joao Incio - Massachusetts General Hospital, Boston, USA
Obesity promotes pancreatic cancer progression and resistance ( Dr Joao Incio - Massachusetts General Hospital, Boston, USA )
14 Jul 2016
Connections in cancer-host immune signalling
Dr Alan Serrels - University of Edinburgh, Edinburgh, UK
Connections in cancer-host immune signalling ( Dr Alan Serrels - University of Edinburgh, Edinburgh, UK )
14 Jul 2016
Targeting and imaging invasion and metastasis
Prof Margaret Frame - Edinburgh Cancer Research Centre, Edinburgh, UK
Targeting and imaging invasion and metastasis ( Prof Margaret Frame - Edinburgh Cancer Research Centre, Edinburgh, UK )
14 Jul 2016

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation